GapDB find and trade gaps by statistics
Biotech IBB+XBI 1Y Gap Scan
Updated 2026-07-11
click to sort
| Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
|---|---|---|---|---|---|
| Biogen Inc. - Common Stock | BIIB | 9 | 7 | 2 | 22.2 |
| Immix Biopharma, Inc. - Common Stock | IMMX | 2 | 2 | 0 | 0.0 |
| Vericel Corporation - Common Stock | VCEL | 3 | 2 | 1 | 33.3 |
| CareDx, Inc. - Common Stock | CDNA | 4 | 3 | 1 | 25.0 |
| Prime Medicine, Inc. - Common Stock | PRME | 5 | 4 | 1 | 20.0 |
| Spyre Therapeutics, Inc. - Common Stock | SYRE | 5 | 3 | 2 | 40.0 |
| Absci Corporation - Common Stock | ABSI | 8 | 6 | 2 | 25.0 |
| Recursion Pharmaceuticals, Inc. - Class A Common Stock | RXRX | 8 | 8 | 0 | 0.0 |
| Disc Medicine, Inc. - Common Stock | IRON | 4 | 4 | 0 | 0.0 |
| Mirum Pharmaceuticals, Inc. - common stock | MIRM | 3 | 0 | 3 | 100.0 |
| Erasca, Inc. - Common Stock | ERAS | 2 | 1 | 1 | 50.0 |
| Oruka Therapeutics, Inc. - Common Stock | ORKA | 8 | 4 | 4 | 50.0 |
| Roivant Sciences Ltd. - Common Shares | ROIV | 6 | 4 | 2 | 33.3 |
| Insmed Incorporated - Common Stock | INSM | 4 | 4 | 0 | 0.0 |
| Revolution Medicines, Inc. - Common Stock | RVMD | 9 | 1 | 8 | 88.9 |
| Sionna Therapeutics, Inc. - Common Stock | SION | 2 | 2 | 0 | 0.0 |
| Vera Therapeutics, Inc. - Class A Common Stock | VERA | 5 | 4 | 1 | 20.0 |
| Compass Therapeutics, Inc. - Common Stock | CMPX | 1 | 1 | 0 | 0.0 |
| Bicara Therapeutics Inc. - Common Stock | BCAX | 2 | 2 | 0 | 0.0 |
| Rhythm Pharmaceuticals, Inc. - Common Stock | RYTM | 4 | 3 | 1 | 25.0 |
| Nurix Therapeutics, Inc. - Common stock | NRIX | 3 | 3 | 0 | 0.0 |
| Neurocrine Biosciences, Inc. - Common Stock | NBIX | 7 | 6 | 1 | 14.3 |
| Gilead Sciences, Inc. - Common Stock | GILD | 4 | 4 | 0 | 0.0 |
| MannKind Corporation - Common Stock | MNKD | 5 | 4 | 1 | 20.0 |
| Rigel Pharmaceuticals, Inc. - Common Stock | RIGL | 6 | 4 | 2 | 33.3 |
| Prothena Corporation plc - Ordinary Shares | PRTA | 2 | 1 | 1 | 50.0 |
| Vaxcyte, Inc. - Common Stock | PCVX | 3 | 3 | 0 | 0.0 |
| Moderna, Inc. - Common Stock | MRNA | 9 | 8 | 1 | 11.1 |
| Jade Biosciences, Inc. - Common Stock | JBIO | 1 | 1 | 0 | 0.0 |
| Madrigal Pharmaceuticals, Inc. - Common Stock | MDGL | 1 | 1 | 0 | 0.0 |
| Krystal Biotech, Inc. - Common Stock | KRYS | 5 | 3 | 2 | 40.0 |
| IDEAYA Biosciences, Inc. - Common Stock | IDYA | 5 | 5 | 0 | 0.0 |
| Verastem, Inc. - Common Stock | VSTM | 2 | 2 | 0 | 0.0 |
| Allogene Therapeutics, Inc. - Common Stock | ALLO | 8 | 8 | 0 | 0.0 |
| ImmunityBio, Inc. - Common Stock | IBRX | 9 | 8 | 1 | 11.1 |
| BioCryst Pharmaceuticals, Inc. - Common Stock | BCRX | 1 | 1 | 0 | 0.0 |
| Ionis Pharmaceuticals, Inc. - Common Stock | IONS | 8 | 5 | 3 | 37.5 |
| PTC Therapeutics, Inc. - Common Stock | PTCT | 7 | 5 | 2 | 28.6 |
| Protagonist Therapeutics, Inc. - Common Stock | PTGX | 1 | 0 | 1 | 100.0 |
| Vir Biotechnology, Inc. - Common Stock | VIR | 7 | 4 | 3 | 42.9 |
| Vertex Pharmaceuticals Incorporated - Common Stock | VRTX | 6 | 5 | 1 | 16.7 |
| Dianthus Therapeutics, Inc. - Common Stock | DNTH | 4 | 2 | 2 | 50.0 |
| Iovance Biotherapeutics, Inc. - Common Stock | IOVA | 7 | 5 | 2 | 28.6 |
| Candel Therapeutics, Inc. - Common Stock | CADL | 5 | 3 | 2 | 40.0 |
| Nuvalent, Inc. - Class A Common Stock | NUVL | 2 | 1 | 1 | 50.0 |
| ArriVent BioPharma, Inc. - Common Stock | AVBP | 3 | 3 | 0 | 0.0 |
| Ardelyx, Inc. - Common Stock | ARDX | 11 | 10 | 1 | 9.1 |
| Solid Biosciences Inc. - Common Stock | SLDB | 6 | 6 | 0 | 0.0 |
| Lexeo Therapeutics, Inc. - Common Stock | LXEO | 3 | 3 | 0 | 0.0 |
| Geron Corporation - Common Stock | GERN | 1 | 1 | 0 | 0.0 |
| Arcutis Biotherapeutics, Inc. - Common stock | ARQT | 4 | 3 | 1 | 25.0 |
| Taysha Gene Therapies, Inc. - Common Stock | TSHA | 9 | 6 | 3 | 33.3 |
| REGENXBIO Inc. - Common Stock | RGNX | 9 | 6 | 3 | 33.3 |
| Halozyme Therapeutics, Inc. - Common Stock | HALO | 5 | 3 | 2 | 40.0 |
| CG Oncology, Inc. - Common stock | CGON | 5 | 4 | 1 | 20.0 |
| Celcuity Inc. - Common Stock | CELC | 4 | 2 | 2 | 50.0 |
| First Tracks Biotherapeutics, Inc. - Ordinary Shares | TRAX | 1 | 0 | 1 | 100.0 |
| Tyra Biosciences, Inc. - Common Stock | TYRA | 2 | 1 | 1 | 50.0 |
| MapLight Therapeutics, Inc. - Common Stock | MPLT | 3 | 1 | 2 | 66.7 |
| ARS Pharmaceuticals, Inc. - Common Stock | SPRY | 1 | 1 | 0 | 0.0 |
| Oric Pharmaceuticals, Inc. - Common Stock | ORIC | 3 | 3 | 0 | 0.0 |
| Perspective Therapeutics, Inc. Common Stock | CATX | 2 | 2 | 0 | 0.0 |
| Ironwood Pharmaceuticals, Inc. - Class A Common Stock | IRWD | 6 | 3 | 3 | 50.0 |
| Relay Therapeutics, Inc. - Common Stock | RLAY | 4 | 3 | 1 | 25.0 |
| Cytokinetics, Incorporated - Common Stock | CYTK | 4 | 2 | 2 | 50.0 |
| Incyte Corporation - Common Stock | INCY | 7 | 4 | 3 | 42.9 |
| ADMA Biologics Inc - Common Stock | ADMA | 4 | 3 | 1 | 25.0 |
| Kymera Therapeutics, Inc. - Common Stock | KYMR | 5 | 4 | 1 | 20.0 |
| Vor Biopharma Inc. - Common Stock | VOR | 5 | 4 | 1 | 20.0 |
| Viking Therapeutics, Inc. - Common Stock | VKTX | 6 | 6 | 0 | 0.0 |
| ACADIA Pharmaceuticals Inc. - Common Stock | ACAD | 9 | 7 | 2 | 22.2 |
| AnaptysBio, Inc. - Common Stock | ANAB | 2 | 0 | 2 | 100.0 |
| Precigen, Inc. - Common Stock | PGEN | 8 | 5 | 3 | 37.5 |
| Praxis Precision Medicines, Inc. - Common Stock | PRAX | 4 | 2 | 2 | 50.0 |
| Savara, Inc. - Common Stock | SVRA | 2 | 2 | 0 | 0.0 |
| Ovid Therapeutics Inc. - Common Stock | OVID | 6 | 5 | 1 | 16.7 |
| MiMedx Group, Inc - Common Stock | MDXG | 4 | 4 | 0 | 0.0 |
| Myriad Genetics, Inc. - Common Stock | MYGN | 1 | 1 | 0 | 0.0 |
| Viridian Therapeutics, Inc. - Common Stock | VRDN | 5 | 4 | 1 | 20.0 |
| Celldex Therapeutics, Inc. - Common Stock | CLDX | 5 | 4 | 1 | 20.0 |
| Cogent Biosciences, Inc. - Common Stock | COGT | 10 | 8 | 2 | 20.0 |
| United Therapeutics Corporation - Common Stock | UTHR | 5 | 3 | 2 | 40.0 |
| AbbVie Inc. Common Stock | ABBV | 9 | 8 | 1 | 11.1 |
| Scholar Rock Holding Corporation - Common Stock | SRRK | 3 | 2 | 1 | 33.3 |
| CRISPR Therapeutics AG - Common Shares | CRSP | 8 | 8 | 0 | 0.0 |
| Biohaven Ltd. Common Shares | BHVN | 5 | 4 | 1 | 20.0 |
| Corvus Pharmaceuticals, Inc. - Common Stock | CRVS | 3 | 2 | 1 | 33.3 |
| Veracyte, Inc. - Common Stock | VCYT | 10 | 6 | 4 | 40.0 |
| Ultragenyx Pharmaceutical Inc. - Common Stock | RARE | 1 | 1 | 0 | 0.0 |
| Dyne Therapeutics, Inc. - Common Stock | DYN | 7 | 7 | 0 | 0.0 |
| BioMarin Pharmaceutical Inc. - Common Stock | BMRN | 6 | 4 | 2 | 33.3 |
| Intellia Therapeutics, Inc. - Common Stock | NTLA | 5 | 5 | 0 | 0.0 |
| Ocugen, Inc. - Common Stock | OCGN | 4 | 3 | 1 | 25.0 |
| Summit Therapeutics Inc. - Common Stock | SMMT | 3 | 3 | 0 | 0.0 |
| Sarepta Therapeutics, Inc. - Common Stock | SRPT | 8 | 7 | 1 | 12.5 |
| Cullinan Therapeutics, Inc. - Common Stock | CGEM | 5 | 5 | 0 | 0.0 |
| Monte Rosa Therapeutics, Inc. - Common Stock | GLUE | 6 | 4 | 2 | 33.3 |
| Capricor Therapeutics, Inc. - Common Stock | CAPR | 7 | 5 | 2 | 28.6 |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 5 | 3 | 2 | 40.0 |
| Hyperliquid Strategies Inc - Common Stock | PURR | 12 | 9 | 3 | 25.0 |
| Atrium Therapeutics, Inc. - Common Stock | RNA | 0 | 0 | 0 | 0.0 |
| Tango Therapeutics, Inc. - Common Stock | TNGX | 3 | 2 | 1 | 33.3 |
| Apogee Therapeutics, Inc. - Common Stock | APGE | 6 | 4 | 2 | 33.3 |
| Immunome, Inc. - Common Stock | IMNM | 6 | 6 | 0 | 0.0 |
| Arbutus Biopharma Corporation - Common Stock | ABUS | 3 | 3 | 0 | 0.0 |
| uniQure N.V. - Ordinary Shares | QURE | 10 | 8 | 2 | 20.0 |
| Alkermes plc - Ordinary Shares | ALKS | 9 | 6 | 3 | 33.3 |
| SELLAS Life Sciences Group, Inc. - Common Stock | SLS | 8 | 5 | 3 | 37.5 |
| Inhibrx Biosciences, Inc. - Common Stock | INBX | 7 | 4 | 3 | 42.9 |
| Twist Bioscience Corporation - Common Stock | TWST | 10 | 8 | 2 | 20.0 |
| Stoke Therapeutics, Inc. - Common Stock | STOK | 4 | 4 | 0 | 0.0 |
| Janux Therapeutics, Inc. - Common Stock | JANX | 4 | 4 | 0 | 0.0 |
| Beam Therapeutics Inc. - Common Stock | BEAM | 8 | 7 | 1 | 12.5 |
| Zenas BioPharma, Inc. - Common Stock | ZBIO | 3 | 2 | 1 | 33.3 |
| Exelixis, Inc. - Common Stock | EXEL | 5 | 4 | 1 | 20.0 |
| BridgeBio Oncology Therapeutics, Inc. - Common Stock | BBOT | 1 | 1 | 0 | 0.0 |
| Syndax Pharmaceuticals, Inc. - Common Stock | SNDX | 5 | 2 | 3 | 60.0 |
| BridgeBio Pharma, Inc. - Common Stock | BBIO | 9 | 5 | 4 | 44.4 |
| Altimmune, Inc. - Common Stock | ALT | 4 | 4 | 0 | 0.0 |
| Palvella Therapeutics, Inc. - Common Stock | PVLA | 9 | 5 | 4 | 44.4 |
| Kodiak Sciences Inc - Common Stock | KOD | 6 | 2 | 4 | 66.7 |
| Arrowhead Pharmaceuticals, Inc. - Common Stock | ARWR | 11 | 7 | 4 | 36.4 |
| Arcus Biosciences, Inc. Common Stock | RCUS | 7 | 4 | 3 | 42.9 |
| Novavax, Inc. - Common Stock | NVAX | 7 | 5 | 2 | 28.6 |
| CytomX Therapeutics, Inc. - Common Stock | CTMX | 1 | 1 | 0 | 0.0 |
| Sana Biotechnology, Inc. - Common Stock | SANA | 4 | 4 | 0 | 0.0 |
| Replimune Group, Inc. - Common Stock | REPL | 7 | 4 | 3 | 42.9 |
| Amgen Inc. - Common Stock | AMGN | 8 | 6 | 2 | 25.0 |
| Xencor, Inc. - Common Stock | XNCR | 4 | 3 | 1 | 25.0 |
| Achieve Life Sciences, Inc. - Common Shares | ACHV | 6 | 3 | 3 | 50.0 |
| Natera, Inc. - Common Stock | NTRA | 7 | 6 | 1 | 14.3 |
| Mineralys Therapeutics, Inc. - Common Stock | MLYS | 4 | 2 | 2 | 50.0 |
| GRAIL, Inc. - Common Stock | GRAL | 8 | 8 | 0 | 0.0 |
| Immunovant, Inc. - Common Stock | IMVT | 5 | 0 | 5 | 100.0 |
| TG Therapeutics, Inc. - Common Stock | TGTX | 6 | 3 | 3 | 50.0 |
| Vanda Pharmaceuticals Inc. - Common Stock | VNDA | 6 | 5 | 1 | 16.7 |
| 4D Molecular Therapeutics, Inc. - Common Stock | FDMT | 5 | 4 | 1 | 20.0 |
| Kura Oncology, Inc. - Common Stock | KURA | 8 | 5 | 3 | 37.5 |
| Travere Therapeutics, Inc. - Common Stock | TVTX | 5 | 3 | 2 | 40.0 |
| Alnylam Pharmaceuticals, Inc. - Common Stock | ALNY | 5 | 5 | 0 | 0.0 |
| Annexon, Inc. - common stock | ANNX | 5 | 4 | 1 | 20.0 |
| Denali Therapeutics Inc. - Common Stock | DNLI | 6 | 6 | 0 | 0.0 |
| Cabaletta Bio, Inc. - Common Stock | CABA | 3 | 3 | 0 | 0.0 |
| Damora Therapeutics, Inc. - Common Stock | DMRA | 0 | 0 | 0 | 0.0 |
| Catalyst Pharmaceuticals, Inc. - Common Stock | CPRX | 6 | 3 | 3 | 50.0 |
| Agios Pharmaceuticals, Inc. - Common Stock | AGIO | 5 | 3 | 2 | 40.0 |
| Avalo Therapeutics, Inc. - Common Stock | AVTX | 5 | 3 | 2 | 40.0 |
| Emergent BioSolutions Inc. Common Stock | EBS | 10 | 9 | 1 | 10.0 |
| Regeneron Pharmaceuticals, Inc. - Common Stock | REGN | 5 | 3 | 2 | 40.0 |
Gap Statistics:
Must-Read Books on Technical Analysis:
Japanese Candlestick Charting Techniques by Steve Nison
Technical Analysis of the Financial Markets by John Murphy
